NCT01107964View on ClinicalTrials.gov

Oral Omega-3 Fatty Acids in the Treatment of Dry Eye Syndrome

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

August 31, 2014

Study Completion Date

June 15, 2015

Conditions
Dry Eye Syndrome
Interventions
DRUG

Oral Omega-3-acid ethyl esters

1 gram capsule by mouth four times daily for 45 days

DRUG

Placebo corn oil capsule

1 gram by mouth 4 times daily for 45 days

Trial Locations (1)

17033

Penn State Hershey Eye Center, Hershey

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

The American Society of Cataract and Refractive Surgery Foundation

OTHER

collaborator

GlaxoSmithKline

INDUSTRY

lead

Milton S. Hershey Medical Center

OTHER

NCT01107964 - Oral Omega-3 Fatty Acids in the Treatment of Dry Eye Syndrome | Biotech Hunter | Biotech Hunter